Clinical trial

Study in Subjects With Mild-to-Moderate Alzheimer's Dementia

NCT05834296

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2023-07-05

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2023-07-05Date precision: day

Registry last updated2026-09-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

ALZN002 (autologous DCs pulsed with E22W mutant peptide).BIOLOGICAL

PlaceboDRUG

Sponsors & collaborators

Alzamend Neuro, Inc.lead sponsor

bioRASI, LLCcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05834296 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.